The other two carriers of pathogenic missense variants in Lynch Syndrome genes, MLH1 and MSH2, in our study had HPV16‐positive adenocarcinoma or squamous cervical cancer, respectively. This evidence concerns the gene MSH2 and Lynch syndrome.